Artificial Pancreas Device System Market

ethansmith

Global Artificial

Pancreas Device

System Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2015

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Pancreas is one of the major endocrine gland which secretes hormones released directly

into the blood. Pancreas is around 6 inches long located in the abdominal cavity. Pancreas

produce the vital hormones of insulin, pancreatic polypeptide, glucagon and

somatostatin. Pancreas aid in digestion and absorption processes by secreting the

pancreatic juice which contains digestive enzymes. The Artificial Pancreas Device System

is used in the treatment of Type 1 Diabetes. Type 1 diabetes patients require multiple

doses of insulin in a day and all-round the year. The Artificial Pancreas Device System is

also referred to as the closed-loop system or autonomous system for glycemic control or

bionic pancreas. The Artificial Pancreas Device System simulates the glucose regulation

function of a healthy pancreas. The continuous glucose monitoring is done by placing the

sensor subcutaneously to measure the glucose level in the fluid around the cells. A

transmitter sends information of glucose level estimates and their rate of change to the

receiver. Control algorithm software embedded in an external controller performs

mathematical calculations to send dosing instruction to the insulin infusion pumps,

computer or smartphone. Depending on the dosing instructions, the insulin infusion

pump regulates the level of insulin delivery to the subcutaneous tissue.

Browse Full Report@ http://www.futuremarketinsights.com/reports/artificial-pancreasdevice-system-market

Artificial Pancreas Device System Market: Drivers & Restraints

The Food and Drug Administration (FDA) is collaborating with private and government

research institutions to improvise clinical studies and accelerate the development of the


Report Description

the FDA released a document on requirements of clinical studies and premarket approval

applications for the production Artificial Pancreas Device Systems. This will encourage the

manufacturing of Artificial Pancreas Device Systems and drive the growth of the global

Artificial Pancreas Device System market. The patients need to calibrate the continuous

glucose monitor at equal intervals. Also, the continuous glucose monitoring sensors are

subjected to biofouling and fibrosis when they are placed subcutaneously which alters

the productivity of sensors. The FDA has identified issues in the components and

software of insulin infusion pumps. The insulin used currently in the Artificial Pancreas

Device Systems takes longer duration of time to completely absorb. Such factors related

to Artificial Pancreas Device Systems could potentially hamper the growth of the global

Artificial Pancreas Device Systems market.

Artificial Pancreas Device System Market: Segmentation

Artificial Pancreas Device System market is classified on the basis product type and

geography.

Based on product type, the global Artificial Pancreas Device System market is segmented

into the following:

Threshold Suspend Device System

Control-to-Range (CTR) System

Control -to-Target (CTT) System


Report Description

Artificial Pancreas Device System Market: Overview

The concentration of glucose in the blood of the patient is very dynamic and is affected

by the patient’s physical activity and diet. The Artificial Pancreas Device System helps in

the sustenance of life of type 1 diabetes patients. The Artificial Pancreas Device System

does the function of beta cells of a healthy pancreas. Type 1 diabetes patient have to

closely monitor blood glucose levels in order to avoid hyperglycemia and hypoglycemia

which leads to long-term diabetes complications such as seizures, coma and even death.

Thus, blood glucose monitoring on a daily basis is essential and the Artificial Pancreas

Device System is the solution to it.

Request Report Sample with TOC@

http://www.futuremarketinsights.com/reports/sample/rep-gb-974

Artificial Pancreas Device System Market: Region-wise Outlook

Depending on geographic regions, global Artificial Pancreas Device System market is

segmented into seven key regions: North America, South America, Eastern Europe,

Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. India,

China, USA, Indonesia, Pakistan and Japan are the top six countries with the highest

number of estimated cases of diabetes. As a result, Asia Pacific and North America are

anticipated to be the potential markets for the global Artificial Pancreas Device System

market players.


Report Description

Artificial Pancreas Device System Market: Key Players

Some of the key market players in global Artificial Pancreas Device System market are

Pancreum, LLC, Medtronic, Inc. and JDRF. In the near future, the global Artificial Pancreas

Device System manufacturers have to develop products which will not only monitor but

also adjust the blood glucose levels rapidly without the need of intervention of the

patient.


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines